GlassScriptPhysician profile
Andrew J Kelly
NPI 1588922215
$2,211.91
in general payments reported to CMS, 2019-2025
26 companies · $50.05 in 2025
The $50.05 reported for 2025 was less than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $593 · 2020: $169 · 2021: $401 · 2022: $557 · 2023: $416 · 2024: $25.61 · 2025: $50.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $492.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $491.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $486.61 | 2019-2023 | |
| Pfizer INC. | $289.86 | 2019-2023 | |
| Janssen Biotech, INC. | $240.14 | 2022 | |
| Amgen INC. | $204.92 | 2019-2022 | |
| Glaxosmithkline, LLC. | $196.91 | 2019-2023 | Benlysta |
| Astrazeneca Pharmaceuticals LP | $91.02 | 2022-2023 | Saphnelo |
| Aurinia Pharma U.S., INC. | $80.38 | 2021 | |
| Novartis Pharmaceuticals Corporation | $78.27 | 2019-2020 | |
| Astellas Pharma US INC | $75.66 | 2024-2025 | Veozah |
| Genentech USA, INC. | $52.80 | 2019-2021 | |
| Ucb, INC. | $43.88 | 2021 | |
| Alexion Pharmaceuticals, INC. | $41.55 | 2021 | |
| Sobi, INC | $37.91 | 2019 | |
| Mallinckrodt Enterprises LLC | $35.76 | 2019 | |
| Depuy Synthes Sales INC. | $33.14 | 2019-2020 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $30.40 | 2022 | |
| Hikma Pharmaceuticals USA | $28.05 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $26.60 | 2019 | |
| Fresenius Kabi USA, LLC | $25.43 | 2023 | Idacio |
| Pacira Therapeutics, INC. | $20.34 | 2019 | |
| Radius Health, INC. | $20.26 | 2021 | |
| Mallinckrodt Hospital Products INC. | $18.30 | 2020 | |
| Kiniksa Pharmaceuticals, LTD. | $17.32 | 2023 | Arcalyst |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.29 | 2019 | |
| Lilly USA, LLC | $12.24 | 2019 | |
| Sanofi-Aventis U.S. LLC | $10.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Kelly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.